Heterogeneity in Malignant Pleural Mesothelioma.

Oehl, Kathrin; Vrugt, Bart; Opitz, Isabelle; Meerang, Mayura

Oehl, Kathrin; Vrugt, Bart; Opitz, Isabelle; Meerang, Mayura.

Affiliation

Oehl K; Department of Thoracic Surgery, University Hospital Zurich, 8091 Zürich, Switzerland. Kathrin.Oehl@usz.ch.
Vrugt B; Institute of Pathology and Molecular Pathology, University Hospital Zürich, 8091 Zürich, Switzerland. Kathrin.Oehl@usz.ch.
Opitz I; Institute of Pathology and Molecular Pathology, University Hospital Zürich, 8091 Zürich, Switzerland. Bart.Vrugt@usz.ch.
Meerang M; Department of Thoracic Surgery, University Hospital Zurich, 8091 Zürich, Switzerland. Isabelle.Schmitt-Opitz@usz.ch.

Int J Mol Sci ; 19(6)2018 May 30.

Article in En | MEDLINE | ID: mdl-29848954

Subject(s)

Lung Neoplasms/genetics; Mesothelioma/genetics; Antineoplastic Agents/therapeutic use; Genetic Heterogeneity; Humans; Lung Neoplasms/drug therapy; Lung Neoplasms/pathology; Mesothelioma/drug therapy; Mesothelioma/pathology; Mesothelioma, Malignant; Neoplastic Stem Cells/drug effects; Neoplastic Stem Cells/pathology

Key words

cancer stem cells; chemoresistance; inter-tumor heterogeneity; mesothelioma; spatial intra-tumor heterogeneity; targeted therapy; temporal intra-tumor heterogeneity

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Lung Neoplasms / Mesothelioma Limits: Humans Language: En Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Lung Neoplasms / Mesothelioma Limits: Humans Language: En Year: 2018 Type: Article